BPG is committed to discovery and dissemination of knowledge
Number of total visits
33510545
Number of visits today
5279
Number of downloads
16697273
MEMBERSHIP
Cited by in F6Publishing
Number
Citing Articles
1
Stredny C , Rotenberg A , Leviton A , Loddenkemper T . Systemic inflammation as a biomarker of seizure propensity and a target for treatment to reduce seizure propensity. Epilepsia Open 2023;8 :221-34. [PMID: 36524286 DOI: 10.1002/epi4.12684 ] [ Reference Citation Analysis ]
2
Shlobin NA , Sander JW . Current Principles in the Management of Drug-Resistant Epilepsy. CNS Drugs 2022;36 :555-68. [PMID: 35590042 DOI: 10.1007/s40263-022-00922-4 ] [ Reference Citation Analysis ]
3
Manna I , Fortunato F , De Benedittis S , Sammarra I , Bertoli G , Labate A , Gambardella A . Non-Coding RNAs: New Biomarkers and Therapeutic Targets for Temporal Lobe Epilepsy. Int J Mol Sci 2022;23 :3063. [PMID: 35328484 DOI: 10.3390/ijms23063063 ] [ Cited by in Crossref: 4] [ Cited by in F6Publishing: 4 ] [ Article Influence: 4.0 ] [ Reference Citation Analysis ]
4
You J , Huang H , Chan CTY , Li L . Pathological Targets for Treating Temporal Lobe Epilepsy: Discoveries From Microscale to Macroscale. Front Neurol 2021;12 :779558. [PMID: 35069411 DOI: 10.3389/fneur.2021.779558 ] [ Cited by in Crossref: 1] [ Cited by in F6Publishing: 1 ] [ Article Influence: 1.0 ] [ Reference Citation Analysis ]
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345